Figure 1From: A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejectionSynthesis of SCH 546738. Synthesis of SCH 546738 was accomplished by the method outlined with details in Methods section.Back to article page